Navigation Links
ARUP Laboratories' Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
Date:11/9/2011

SALT LAKE CITY, Nov. 9, 2011 /PRNewswire/ -- ARUP Laboratories' pathologist, Ronald L. Weiss, MD, MBA, FCAP, received a Lifetime Achievement Award from the College of American Pathologists at CAP '11, the organization's annual meeting, held this year in Grapevine, Texas. According to the CAP, the award honors members "who have made a broad and positive impact on patient care through the specialty of pathology."

(Logo: http://photos.prnewswire.com/prnh/20110915/SF69370LOGO)

Dr. Weiss is a professor of pathology at the University of Utah School of Medicine and currently serves as a staff hematopathologist at ARUP with service responsibilities in the Hematologic Flow Cytometry Laboratory and the Hematopathology Consultation Service. He has served in various management positions at ARUP, including president/chief operating officer and chief medical officer/director of laboratories. Dr. Weiss is board certified in anatomic and clinical pathology, with subspecialty certification in hematology and medical microbiology. His professional interests are in health policy, laboratory management and administration, including the role of the laboratory in protecting patient safety.

"I am deeply honored to be recognized with this award," said Weiss. "I look forward to many more opportunities to make a positive impact on the field of pathology and laboratory medicine and specifically on meeting the needs of the patients we serve."  

Weiss received his MD from the Creighton University School of Medicine. He trained in anatomic and clinical pathology and completed a fellowship in medical microbiology at the University of Utah before joining the Department of Pathology faculty in 1986. 

He has been an active member of the CAP for more than a quarter of a century, serving on numerous committees and workgroups including the Laboratory Fiscal Management Committee an
'/>"/>

SOURCE ARUP Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. IDEXX Laboratories Acquires the RADIL Reference Laboratory from the University of Missouri
2. VetNostic Laboratories® Announces New Testing for Dog Breeds
3. Access Medical Laboratories, Inc. to Celebrate Grand Opening of New Laboratory Headquarters in Jupiter, Florida
4. Building, Validating & Maintaining Controlled Environment Facilities is Focus of Oct. 18th Seminar in Boston Hosted by Microtest Laboratories
5. MO BIO Laboratories, Inc. Launches the RTS DNase™ Kit
6. Veredus Laboratories Develops Lab-on-Chip Solution to Detect and Differentiate Several Food-Borne Pathogens, Including Escherichia coli (E. coli)
7. IDEXX Laboratories to Present at William Blair 31st Annual Growth Stock Conference
8. Trimega Laboratories Honoured to Represent UK at the European Business Awards
9. Trimega Laboratories to Represent UK in Europes Most Competitive Business Awards Competition
10. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
11. Sigma® Life Science and Kraig Biocraft Laboratories to Develop Silkworms for the Production of Spider Silk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Discovery ... diagnostic tests are key drivers of the global molecular diagnostics market. BCC Research ... the introduction of new companion diagnostic tests will increase demand for inexpensive and ...
(Date:7/5/2015)... ... July 06, 2015 , ... For many years, metal-on-quartz filters were the industry ... such as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu 3600-3700, ... NIST used them for their SRM-2031 series going back for many years. Unfortunately, these ...
(Date:7/3/2015)... , July 3, 2015 ... till 22 september 2015 på  http://www.openinnovationinscience.at ... Innovation in Science" som hålls i ... en färsk undersökning med internationella forskare och ... (LBG) är hälsovetenskapens två största utmaningar bristen ...
(Date:7/2/2015)... ELLYN, Ill. , July 2, 2015 ... Colton Eakins are gaining invaluable real-world experiences ... of Technology this summer. The students will ... Dr. Jeff Wereszczynski,s research group at IIT. The ... Dr. Tom Carter , Physics; Dr. Kathy ...
Breaking Biology Technology:Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3COD Students Participate in Prestigious Summer Internships 2
... ET, LOS ANGELES, Aug. 31 Signalife, Inc. (Amex:,SGN), Lowell ... update since his matriculation into the Presidency,last month: 1. Dr. ... positions that were producing no revenue whatsoever and no ... Company, in his view. That was done ...
... Aug. 30 Cepheid (Nasdaq:,CPHD) will present at ... the Four Seasons Hotel, Boston, September 5 to ... Senior Vice President, Finance and,Chief Financial Officer, John ... on,September 7. The webcast, along with accompanying ...
... ON, Aug. 30 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... oncology company that identifies,develops and commercializes differentiated products ... subsidiary, YM BioSciences USA,Inc. ("YM-USA") has been cleared ... initiate a Phase II trial investigating nimotuzumab in ...
Cached Biology Technology:Signalife Provides Corporate Update 2Signalife Provides Corporate Update 3Cepheid to Present at Thomas Weisel Partners Healthcare Conference 2YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 2YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 3YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 4YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 5
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... According to a new market ... Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & ... MarketsandMarkets, The Natural Language Processing Market is expected to ... for the forecast period 2015-2020. Browse ... igures spread   through 155 P ages and ...
(Date:6/12/2015)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announced the United States Patent ... and identify participants of a video visitation session ... system can: , Identify that the ... process is actually the person participating in the ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... to determine the accuracy of a new rapid screening test ... the developing world, have shown it to be 90 per ... a group of local women in Shanxi province, eastern China. ... Lancet Oncoloy, conclude that the test; careHPV, could provide ...
... illustration of the potential for microbes to prevent disease, ... showed that mice exposed to common stomach bacteria were ... The findings, reported in the journal Nature , ... a lack of exposure to parasites, bacteria and viruses ...
... 19 issue of Science shows that an ... can reverse fisheries collapse. Where traditional "open access" fisheries ... oceans have benefited. Catch shares are common in ... Canada.* They guarantee each shareholder a fixed portion of ...
Cached Biology News:HPV DNA test identifies cervical pre-cancerous disease in developing countries with 90% success rate 2'Friendly' bacteria protect against type 1 diabetes, Yale researchers find 2New study offers solution to global fisheries collapse 2New study offers solution to global fisheries collapse 3New study offers solution to global fisheries collapse 4
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Mouse monoclonal antibody raised against a partial recombinant NR4A2. NCBI Entrez Gene ID = NR4A2...
... offers a DNA sequencing service. We can ... PCR products, BACs, etc. Our DNA sequencing ... purified plasmids or purified PCR products. We ... for automated reaction setup and dye terminator ...
... system for fluorescent light due to small ... camera to detect low level light in ... disease research, gene expression, circadian rhythm, gels ... imager with a motor-driven camera inside the ...
Biology Products: